TCL Archive Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease October 31, 2014
TCL Archive FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma. February 17, 2006
TCL Archive NCI Proposes Inviting Academic Labs To Submit New Therapies For Development January 23, 1998